PortfoliosLab logoPortfoliosLab logo
NEXA vs. NUVB
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NEXA vs. NUVB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nexa Resources S.A. (NEXA) and Nuvation Bio Inc. (NUVB). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NEXA vs. NUVB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
NEXA
Nexa Resources S.A.
24.18%2.67%23.25%22.07%-20.07%-16.38%30.27%
NUVB
Nuvation Bio Inc.
-49.67%236.84%76.16%-21.35%-77.41%-27.35%17.00%

Fundamentals

Market Cap

NEXA:

$1.46B

NUVB:

$1.55B

EPS

NEXA:

$1.00

NUVB:

-$0.60

PS Ratio

NEXA:

0.49

NUVB:

24.56

PB Ratio

NEXA:

1.45

NUVB:

5.08

Total Revenue (TTM)

NEXA:

$2.98B

NUVB:

$62.90M

Gross Profit (TTM)

NEXA:

$588.13M

NUVB:

$54.46M

EBITDA (TTM)

NEXA:

$938.99M

NUVB:

-$199.90M

Returns By Period

In the year-to-date period, NEXA achieves a 24.18% return, which is significantly higher than NUVB's -49.67% return.


NEXA

1D
3.78%
1M
-25.03%
YTD
24.18%
6M
119.80%
1Y
82.44%
3Y*
21.34%
5Y*
2.89%
10Y*

NUVB

1D
5.13%
1M
-22.77%
YTD
-49.67%
6M
21.89%
1Y
157.71%
3Y*
39.54%
5Y*
-15.06%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEXA vs. NUVB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEXA
NEXA Risk / Return Rank: 7979
Overall Rank
NEXA Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
NEXA Sortino Ratio Rank: 7979
Sortino Ratio Rank
NEXA Omega Ratio Rank: 7878
Omega Ratio Rank
NEXA Calmar Ratio Rank: 7878
Calmar Ratio Rank
NEXA Martin Ratio Rank: 7676
Martin Ratio Rank

NUVB
NUVB Risk / Return Rank: 8484
Overall Rank
NUVB Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
NUVB Sortino Ratio Rank: 8585
Sortino Ratio Rank
NUVB Omega Ratio Rank: 8585
Omega Ratio Rank
NUVB Calmar Ratio Rank: 8383
Calmar Ratio Rank
NUVB Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEXA vs. NUVB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nexa Resources S.A. (NEXA) and Nuvation Bio Inc. (NUVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NEXANUVBDifference

Sharpe ratio

Return per unit of total volatility

1.51

1.67

-0.16

Sortino ratio

Return per unit of downside risk

2.10

2.46

-0.35

Omega ratio

Gain probability vs. loss probability

1.28

1.34

-0.06

Calmar ratio

Return relative to maximum drawdown

2.17

2.72

-0.55

Martin ratio

Return relative to average drawdown

4.99

6.64

-1.65

NEXA vs. NUVB - Sharpe Ratio Comparison

The current NEXA Sharpe Ratio is 1.51, which is comparable to the NUVB Sharpe Ratio of 1.67. The chart below compares the historical Sharpe Ratios of NEXA and NUVB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NEXANUVBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.51

1.67

-0.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.05

-0.20

+0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.04

-0.18

+0.14

Correlation

The correlation between NEXA and NUVB is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NEXA vs. NUVB - Dividend Comparison

NEXA's dividend yield for the trailing twelve months is around 0.92%, while NUVB has not paid dividends to shareholders.


TTM20252024202320222021202020192018
NEXA
Nexa Resources S.A.
0.92%1.14%0.00%2.64%6.26%3.36%3.92%6.46%5.04%
NUVB
Nuvation Bio Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

NEXA vs. NUVB - Drawdown Comparison

The maximum NEXA drawdown since its inception was -85.01%, smaller than the maximum NUVB drawdown of -93.39%. Use the drawdown chart below to compare losses from any high point for NEXA and NUVB.


Loading graphics...

Drawdown Indicators


NEXANUVBDifference

Max Drawdown

Largest peak-to-trough decline

-85.01%

-93.39%

+8.38%

Max Drawdown (1Y)

Largest decline over 1 year

-37.31%

-57.55%

+20.24%

Max Drawdown (5Y)

Largest decline over 5 years

-62.86%

-93.35%

+30.49%

Current Drawdown

Current decline from peak

-31.13%

-69.05%

+37.92%

Average Drawdown

Average peak-to-trough decline

-52.25%

-65.43%

+13.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.22%

23.53%

-7.31%

Volatility

NEXA vs. NUVB - Volatility Comparison

Nexa Resources S.A. (NEXA) has a higher volatility of 21.38% compared to Nuvation Bio Inc. (NUVB) at 16.34%. This indicates that NEXA's price experiences larger fluctuations and is considered to be riskier than NUVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NEXANUVBDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.38%

16.34%

+5.04%

Volatility (6M)

Calculated over the trailing 6-month period

49.04%

69.18%

-20.14%

Volatility (1Y)

Calculated over the trailing 1-year period

54.92%

95.04%

-40.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.71%

76.00%

-20.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

58.99%

73.56%

-14.57%

Financials

NEXA vs. NUVB - Financials Comparison

This section allows you to compare key financial metrics between Nexa Resources S.A. and Nuvation Bio Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
895.99M
41.87M
(NEXA) Total Revenue
(NUVB) Total Revenue
Values in USD except per share items

NEXA vs. NUVB - Profitability Comparison

The chart below illustrates the profitability comparison between Nexa Resources S.A. and Nuvation Bio Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
22.8%
99.0%
Portfolio components
NEXA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Nexa Resources S.A. reported a gross profit of 204.37M and revenue of 895.99M. Therefore, the gross margin over that period was 22.8%.

NUVB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Nuvation Bio Inc. reported a gross profit of 41.44M and revenue of 41.87M. Therefore, the gross margin over that period was 99.0%.

NEXA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Nexa Resources S.A. reported an operating income of 197.81M and revenue of 895.99M, resulting in an operating margin of 22.1%.

NUVB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Nuvation Bio Inc. reported an operating income of -34.04M and revenue of 41.87M, resulting in an operating margin of -81.3%.

NEXA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Nexa Resources S.A. reported a net income of 50.35M and revenue of 895.99M, resulting in a net margin of 5.6%.

NUVB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Nuvation Bio Inc. reported a net income of -36.59M and revenue of 41.87M, resulting in a net margin of -87.4%.